• 
  Pablo Berlanga, Gaëlle Pierron, Ludovic Lacroix, Mathieu Chicard, Tiphaine Adam De Beaumais, et al.. The European MAPPYACTS Trial: Precision Medicine Program in Pediatric and Adolescent Patients with Recurrent Malignancies. Cancer Discovery, 2022, 12 (5), pp.1266-1281. ⟨10.1158/2159-8290.CD-21-1136⟩. ⟨hal-04085309⟩
• 
  Antoine Monsel, Caroline Hauw-Berlemont, Miryam Mebarki, Nicholas Heming, Julien Mayaux, et al.. Treatment of COVID-19-associated ARDS with mesenchymal stromal cells: a multicenter randomized double-blind trial. Critical Care, 2022, 26 (1), pp.48. ⟨10.1186/s13054-022-03930-4⟩. ⟨hal-04074359⟩
• 
  Aurelien Mary, Agnes Hartemann, Sophie Liabeuf, Carole Elodie Aubert, Salim Kemel, et al.. Association between metformin use and below-the-knee arterial calcification score in type 2 diabetic patients. Cardiovascular Diabetology, 2017, 16, ⟨10.1186/s12933-017-0509-7⟩. ⟨hal-03555488⟩
• 
  Pierre Bay, Marc Pineton de Chambrun, Vincent Rothstein, Matthieu Mahevas, Nicolas de Prost, et al.. Plasma exchange are not associated with better outcome in MDA5 rapidly-progressive interstitial lung disease. French Intensive Care Society International Congress 2022, 2022, paris, France. pp.54, ⟨10.1186/s13613-022-01016-6⟩. ⟨hal-03831253⟩
• 
  Kenneth Chappell, Abd El Kader Ait Tayeb, Romain Colle, Jérôme Bouligand, Khalil El-Asmar, et al.. The association of ARRB1 polymorphisms with response to antidepressant treatment in depressed patients. Frontiers in Pharmacology, 2022, 13, pp.974570. ⟨10.3389/fphar.2022.974570⟩. ⟨hal-04021229⟩

719

1 879